Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.

Autor: Eckhardt CM; Columbia University Medical Center, New York, USA. cme2113@cumc.columbia.edu., Cummings MJ; Columbia University Medical Center, New York, USA., Rajagopalan KN; Columbia University Medical Center, New York, USA., Borden S; Columbia University Medical Center, New York, USA., Bitan ZC; Columbia University Medical Center, New York, USA., Wolf A; Columbia University Medical Center, New York, USA., Kantor A; Columbia University Medical Center, New York, USA., Briese T; Columbia University Medical Center, New York, USA., Meyer BJ; Columbia University Medical Center, New York, USA., Jacobson SD; Columbia University Medical Center, New York, USA., Scotto D; Columbia University Medical Center, New York, USA., Mishra N; Columbia University Medical Center, New York, USA., Philip NM; Columbia University Medical Center, New York, USA., Stotler BA; Columbia University Medical Center, New York, USA., Schwartz J; Columbia University Medical Center, New York, USA., Shaz B; Columbia University Medical Center, New York, USA., Spitalnik SL; Columbia University Medical Center, New York, USA., Eisenberger A; Columbia University Medical Center, New York, USA., Hod Jessica Justman EA; Columbia University Medical Center, New York, USA., Cheung K; Columbia University Medical Center, New York, USA., Lipkin WI; Columbia University Medical Center, New York, USA., O'Donnell MR; Columbia University Medical Center, New York, USA.

Publikováno v: Trials [Trials] 2020 Nov 17; Vol. 21 (1), pp. 927. Date of Electronic Publication: 2020 Nov 17.